NCT00456937View on ClinicalTrials.gov

Escitalopram in Schizophrenia in OCD- Open Label Study

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Schizophrenia
Interventions
DRUG

Escitalopram

Trial Locations (1)

70350

Beer Yaakov MHC, Beer Yaakov

All Listed Sponsors
collaborator

Lundbeck Israel

INDUSTRY

lead

BeerYaakov Mental Health Center

OTHER_GOV

NCT00456937 - Escitalopram in Schizophrenia in OCD- Open Label Study | Biotech Hunter | Biotech Hunter